Connect with us

Published

on

Employees working in Precision’s manufacturing facility

Courtesy: Precision Neuroscience

Neurotech startup Precision Neuroscience announced Thursday it has acquired a factory in Dallas, where it will build the key component of its brain implant, the Layer 7 Cortical Interface. The facility will help the company speed up development and move closer to the regulatory approval it is hoping to clinch in 2024.

The company has started testing its brain implant on human patients and believes it could ultimately help people with paralysis operate digital devices with their brain signals. Precision said the manufacturing plant is the only facility capable of producing its “sophisticated” electrode array.

“It allows us to iterate really quickly, improve performance, longevity, different form factors of the device — all the things that we’ve always wanted to do, we can now do in much quicker succession,” co-founder and CEO Michael Mager told CNBC in an interview. 

Precision’s electrode array is thinner than a human hair and could easily be mistaken for a piece of Scotch tape. The system’s flexible design allows it to rest on the brain’s surface and generate a real-time, high resolution rendering of neural activity without damaging any tissue.

Stephanie Rider of Precision Neuroscience inspects the company’s microelectrode array

Source: Precision Neuroscience

As a member of the fast-growing brain-computer interface (BCI) industry, Precision is developing its technology alongside other companies like Synchron, Paradromics, Blackrock Neurotech and Elon Musk’s Neuralink. Precision’s co-founder and chief science officer, Dr. Benjamin Rapoport, also helped co-found Neuralink before departing the company in 2018.

Neuralink is perhaps the best-known company in the BCI space thanks to the high profile of Musk, who is the CEO of Tesla and SpaceX. The company is taking a more invasive approach with its implant than Precision. Neuralink also manufactures its technology in-house. 

Mager said it can be difficult to make rapid design changes, protect trade secrets and keep supply levels up when working with third parties during the manufacturing process. He added that it’s much easier to ensure that Precision’s arrays are safe and of high quality when the company is directly involved with production.  

“We manufacture systems that go on human brains. The responsibility is really tremendous,” Mager said. 

At the request of the seller, a Japanese multinational corporation, Precision declined to share how much the manufacturing facility cost. Mager said the company was able to retain the 11 “key personnel” who were working there, and there’s a possibility that number will grow with time. Keeping the employees on board was a big victory for Precision, as it meant the company did not have to teach new workers how to handle the complex technology. 

Employees working in Precision’s manufacturing facility

Courtesy: Precision Neuroscience

Precision has been up and running at the facility since May, and it has already made a material difference in the company’s supply levels. Mager said previously that Precision worked with a facility that took over a year to manufacture six arrays, and now, the company can manufacture more than 100 arrays in a single week. 

The arrays coming from the new facility will help Precision keep up with the intense pace of regulatory testing, and it will also aid the company as it gears up for additional human trials at the University of Pennsylvania and at the Mount Sinai Health System in New York City.

“I think, ultimately, the value that we have the potential to create is a lot greater as a result of being in complete control and owning 100% of the facility that is helping to drive all this innovation,” Mager said. “But it is a longer, more capital-intensive game.”  

Precision has been working closely with regulators, but the company still needs to go through several rounds of rigorous safety and efficacy testing before it will receive approval from the Food and Drug Administration to commercialize its technology. 

But the FDA recently gave Precision a nod, as the company announced Thursday it has received a Breakthrough Device designation from the agency. The designation is awarded to medical devices that have the potential to provide improved treatment for debilitating or life-threatening conditions, and the FDA has granted 109 of them in fiscal 2023 so far, according to its website. 

Mager said the designation will open a more frequent line of communication between Precision and the agency that will help expedite the company’s path toward commercialization. He said that with the manufacturing facility, the Breakthrough Device designation and in-patient trials in the works, Precision has the momentum it needs to move forward.  

“It’s never been more exciting,” he said. 

Continue Reading

Technology

Mark Zuckerberg says Meta AI has 1 billion monthly active users

Published

on

By

Mark Zuckerberg says Meta AI has 1 billion monthly active users

Meta CEO Mark Zuckerberg appears at the Meta Connect event in Menlo Park, California, on Sept. 25, 2024.

David Paul Morris | Bloomberg | Getty Images

Meta’s AI assistant now has 1 billion monthly active users across the company’s family of apps, CEO Mark Zuckerberg said Wednesday at the company’s annual shareholder meeting.

The “focus for this year is deepening the experience and making Meta AI the leading personal AI with an emphasis on personalization, voice conversations and entertainment,” Zuckerberg said.

The artificial intelligent assistant’s 1 billion milestone comes after the company in April released a standalone app for the tool.

The plan is for Meta to keep growing the product before building a business around it, Zuckerberg said on Wednesday. As Meta AI improves overtime, Zuckerberg said “there will be opportunities to either insert paid recommendations” or offer “a subscription service so that people can pay to use more compute.”

In February, CNBC reported that Meta was planning to debut a standalone Meta AI app during the second quarter and test a paid-subscription service akin to rival chat apps like OpenAI’s ChatGPT.

“It may seem kind of funny that a billion monthly actives doesn’t seem like it’s at scale for us, but that’s where we’re at,” Zuckerberg told shareholders.

During the Meta shareholder meeting, investors voted on 14 different items related to the company’s business, nine of which were shareholder proposals covering topics such as child safety, greenhouse gas emissions and a proposed bitcoin treasury assessment.

Shareholder proposal 8, for example, was submitted by JLens, which is an investment advisor and affiliate of the Anti-Defamation League, and called for Meta to prepare an annual report detailing and addressing hate content, including antisemitism, on its services following January policy changes that relaxed content-moderation guidelines.

Early voting results on Wednesday showed the proposals that Meta’s board did not recommend were unlikely to pass, including one calling for the company to end its dual-class share structure, which gives Zuckerberg significant voting power. Meanwhile, the voting items that the board favored, including those pertaining to approving the company’s board of director nominees and an equity incentive plan, were likely to pass, based on the preliminary results.

Meta said final polling results will be released within four business days on the company’s website and the U.S. Securities and Exchange Commission.

WATCH: Okta shares fall more than 11% on uncertain outlook.

Okta shares fall more than 11% on uncertain outlook

Continue Reading

Technology

Salesforce turns in strong results and optimistic forecast

Published

on

By

Salesforce turns in strong results and optimistic forecast

Salesforce CEO Marc Benioff participates in an interview at the World Economic Forum in Davos, Switzerland, on Jan. 22, 2025.

Chris Ratcliffe | Bloomberg | Getty Images

Salesforce shares were volatile in extended trading on Wednesday after the sales and customer service software maker reported upbeat fiscal first-quarter results and guidance.

Here’s how the company performed relative to LSEG consensus:

  • Earnings per share: $2.58 adjusted vs. 2.54 expected
  • Revenue: $9.83 billion vs. $9.75 billion expected

Salesforce’s revenue grew 7.6% year over year in the quarter, which ended on April 30, according to a statement. Net income of $1.54 billion, or $1.59 per share, was basically flat compared with $1.53 billion, or $1.56 per share, a year ago.

President Donald Trump announced sweeping tariffs on goods imported into the U.S. in early April. Co-founder and CEO Marc Benioff sounded positive about the company’s results for the quarter anyway, pointing to its plan, announced on Tuesday, to buy data management company Informatica for $8 billion.

It would be Salesforce’s priciest acquisition since the $27.1 billion Slack deal in 2021. Slack marked the top end of the buyouts Salesforce had made under Benioff. Activist investors raised concerns about all the spending, in addition to slowing revenue growth.

Salesforce sprung into action, slashing 10% of its headcount. Benioff proclaimed that the board’s mergers and acquisitions committee had been disbanded. The company’s finance chief at the time said it would reach a margin expansion goal two years early. And Salesforce started paying dividends to shareholders.

Initial reception to the Informatica announcement was generally favorable. “Salesforce is paying a reasonable multiple for the asset, in our view, and the deal should be more easily digested by investors than some of the company’s large deals in the past (i.e. Slack),” Stifel analysts led by J. Parker Lane wrote in a note to clients. The investment bank has a buy rating on Salesforce shares.

During the fiscal first quarter, Salesforce introduced the AgentExchange marketplace for artificial intelligence agents.

Management sees $2.76 to $2.78 in adjusted earnings per share on $10.11 billion to $10.16 billion in revenue for the fiscal second quarter. Analysts polled by LSEG had expected $2.73 in adjusted earnings per share on $10.01 billion in revenue.

Salesforce bumped up its full-year forecast. It called for $11.27 to $11.33 in adjusted earnings per share and $41.0 billion to $41.3 billion in revenue, implying revenue growth between 8% and 9%. The LSEG consensus included net income of $11.16 per share and $40.82 billion in revenue. The guidance in February was $11.09 to $11.17 in adjusted earnings per share, with $40.5 billion to $40.9 billion in revenue.

As of Wednesday’s close, the stock had slipped about 18% so far in 2025, while the S&P index was unchanged.

Executives will discuss the results with analysts on a conference call starting at 5 p.m. ET.

This is breaking news. Please check back for updates.

WATCH: Salesforce CEO Marc Benioff: Data centers and chips are ‘commodities’

Salesforce CEO Marc Benioff: Data centers and chips are 'commodities'

Continue Reading

Technology

HP sinks 15% as company misses on earnings, guidance due to ‘added cost’ from tariffs

Published

on

By

HP sinks 15% as company misses on earnings, guidance due to 'added cost' from tariffs

Sopa Images | Lightrocket | Getty Images

HP reported second-quarter results that beat analysts’ estimates for revenue but missed on earnings and guidance, in part due to President Donald Trump’s sweeping tariffs. Shares sank 15% after the report.

Here’s how the company did versus analysts’ estimates compiled by LSEG:

  • Earnings per share: 71 cents adjusted vs. 80 cents expected
  • Revenue: $13.22 billion vs. $13.14 billion expected.

Revenue for the quarter increased 3.3% from $12.8 billion in the same period last year. HP reported net income of $406 million, or 42 cents per share, down from $607 million, or 61 cents per share, a year ago.

For its third quarter, HP said it expects to report adjusted earnings of 68 cents to 80 cents per share, missing the average analyst estimate of 90 cents, according to LSEG. Full-year adjusted earnings will be within the range of $3 to $3.30 per share, while analysts were expecting $3.49 per share.

HP said its outlook “reflects the added cost driven by the current U.S. tariffs,” as well as the associated mitigations.

“While results in the quarter were impacted by a dynamic regulatory environment, we responded quickly to accelerate the expansion of our manufacturing footprint and further reduce our cost structure,” HP CEO Enrique Lores said in a statement.

Lores told CNBC’s Steve Kovach that HP has increased production in Vietnam, Thailand, India, Mexico and the U.S. By the end of June, Lores said the company expects nearly all of its products sold in North America will be built outside of China.

“Through our actions, we expect to fully mitigate the increased trade-related costs by Q4,” Lores said in the interview.

HP will hold its quarterly call with investors at 5 p.m. ET.

Don’t miss these insights from CNBC PRO

Continue Reading

Trending